Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services is a leading provider of healthcare workforce solutions that has consistently delivered strong financial performance, surpassing Q1 consensus revenue and EBITDA expectations by 12% and 35%, respectively. The company has a strong track record of generating revenue growth from its Nurse and Allied Solutions segment, which accounted for a majority of its total revenue in recent quarters. Additionally, AMN has been managing its balance sheet effectively, targeting a debt leverage of 2.0x or less in 2026. The company's recent acquisitions of ESSENTIAL Leadership Assessment and Jaide Health reflect its focus on strategic growth opportunities, and we believe that its competitive industry pricing pressures in language services could be partially mitigated by its focus on clinical healthcare settings. With a strong earnings outlook and favorable valuation compared to its historical average, we have a positive outlook on AMN Healthcare Services's stock.

Bears say

AMN Healthcare Services is facing intense competition, with gross margins falling and revenues declining. Despite expected improvements in volume growth and financial metrics, such as adjusted EBITDA and EPS, its multiples may not necessarily follow suit. As such, the stock is currently rated as a buy with a target price of $26.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Aug 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.